Effectiveness of polyvalent bacterial lysate and autovaccines against upper respiratory tract bacterial colonization by potential pathogens: A randomized study

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 2997-3002

  Zagólski, Olaf ^a   Stręk, Paweł ^b   Kasprowicz, Andrzej ^c   Białecka, Anna ^c  

^a St John Grande's Hospital   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c Centre for Microbiological Research and Autovaccines   (Poland)

Author keywords

Aerobic; Autovaccines; Bacteria; Bacterial vaccines; Nose diseases; Pharyngeal diseases

Indexed keywords

AUTOVACCINE; BACTERIUM LYSATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; POLYVELENT BACTERIUM LYSATE; UNCLASSIFIED DRUG; BRONCHO-VAXOM; CELL EXTRACT;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL STRAIN; CLINICAL EFFECTIVENESS; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MITIS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; UPPER RESPIRATORY TRACT; BACTERIAL INFECTIONS; CHEMISTRY; CHRONIC DISEASE; CONTROLLED STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; NOSE DISEASES; ORAL DRUG ADMINISTRATION; PHARYNGEAL DISEASES; PROSPECTIVE STUDY; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTIONS; YOUNG ADULT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AUTOVACCINES; BACTERIAL INFECTIONS; CELL EXTRACTS; CHRONIC DISEASE; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NOSE DISEASES; PHARYNGEAL DISEASES; PROSPECTIVE STUDIES; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 84943233243     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.893779     Document Type: Article

References (28)

1. Anon JB: Upper respiratory infections. Am J Med, 2010; 123: S16–25
2. Dhakal R, Sujatha S, Parija SC, Bhat BV: Asymptomatic colonization of upper respiratory tract by potential bacterial pathogens. Indian J Pediatr, 2010; 77: 775–78
3. Lanzilli G, Falchetti R, Tricarico M et al: In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function. Int J Immunopathol Pharmacol, 2005; 18: 245–54
4. Jareoncharsri P, Bunnag C, Tunsuriyawong P et al: An open-label, prospective study of an oral polyvalent bacterial lysate (Luivac) in the treatment of recurrent respiratory tract infections in Thai patients. Asian Pac J Allergy Immuno, 2003; 21: 223–30
5. Lanzilli G, Falchetti R, Cottarelli A et al: In vivo effect of an immunostimulating bacterial lysate on human B lymphocytes. Int J Immunopathol Pharmaco, 2006; 19: 551–59
6. Rosaschino F, Cattaneo L: Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered Polyvalent Mechanical Bacterial Lysates (PMBL). Acta Biome, 2004; 75: 171–78
7. Faure GC, Béné MC, Simon C, Quantain A: Increase in specific antibodyforming cells in human tonsils after oral stimulation with D-53, a ribosomal vaccine. Int J Immunopharmaco, 1990; 12: 315–20
8. Han L, Zheng CP, Sun YQ et al: A bacterial extract of OM-85 Broncho-Vaxom prevents allergic rhinitis in mice. Am J Rhinol Allergy, 2014; 28: 110–16
9. Bitar MA, Saade R: The role of OM-85 BV (Broncho-Vaxom) in preventing recurrent acute tonsillitis in children. Int J Pediatr Otorhinolaryngol, 2013; 77: 670–73
10. Ricci R, Palmero C, Bazurro G et al: The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes. Pulm Pharmacol Ther, 2014; 27: 109–13
11. Cazzola M, Anapurapu S, Page CP: Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis. Pulm Pharmacol Ther, 2012; 25: 62–68
12. Guaní-Guerra E, Negrete-García MC, Montes-Vizuet R et al: Human b-defensin- 2 induction in nasal mucosa after administration of bacterial lysates. Arch Med Res, 2011; 42: 189–94
13. Béné MC, Kahl L, Perruchet AM et al: Bacterial lysates and ribosomes as inducers of specific immune responses: a comparative study. Scand J Immuno, 1993; 38: 496–98
14. Zanin C, Béné MC, Perruchet AM et al: Bacterial crude extracts or ribosomes are recognized similarly by peripheral and mucosal B cells. FEMS Immunol Med Microbio, 1994; 10: 11–18
15. Rizzo C, Brancaccio G, De Vito D, Rizzo G: Efficacy of autovaccination therapy on post-coronary artery bypass grafting methicillin-resistant Staphylococcus aureus mediastinitis. Interact Cardiovasc Thorac Sur, 2007; 6: 228–29
16. Volgin AR, Demina IuV: Experience of using bacterial lysate IRS 19 for the prophylaxis of the diseases of respiratory organs in organized groups. Zh Mikrobiol Epidemiol Immunobio, 2005; 3: 82–84
17. Bae S, Yu JY, Lee K et al: Nasal colonization by four potential respiratory bacteria in healthy children attending kindergarten or elementary school in Seoul, Korea. J Med Microbio, 2012; 61: 678–85
18. Nadel DM, Lanza DC, Kennedy DW: Endoscopically guided sinus cultures in normal subjects. Am J Rhinol, 1999; 13: 87–90
19. Jomrich N, Kellner S, Djukic M et al: Absence of Streptococcus pneumoniae in pharyngeal swabs of geriatric inpatients. Infect Dis (Lond), 2015; 6: 1–6
20. Tricarico D, Varricchio A, D’Ambrosio S et al: Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial. Arzneimittelforschung, 2004; 54: 57–63
21. Cox RA, Conquest C: Strategies for the management of healthcare staff colonized with epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infec, 1997; 35: 117–27
22. Goerke C, Gressinger M, Endler K et al: High phenotypic diversity in infecting but not in colonizing Staphylococcus aureus populations. Environ Microbio, 2007; 9: 3134–42
23. Libberton B, Coates RE, Brockhurst MA, Horsburgh MJ: Evidence that intraspecific trait variation among nasal bacteria shapes the distribution of Staphylococcus aureus. Infect Immun, 2014; 82: 3811–15
24. Hamdan-Partida A, Sainz-Espuñes T, Bustos-Martínez J: Characterization and persistence of Staphylococcus aureus strains isolated from the anterior nares and throats of healthy carriers in a Mexican community. J Clin Microbio, 2010; 48: 1701–5
25. Puchta A, Verschoor CP, Thurn T, Bowdish DM: Characterization of inflammatory responses during intranasal colonization with Streptococcus pneumoniae. J Vis Exp, 2014; 17: e50490
26. Wu K, Yao R, Wang H et al: Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice. Vaccine, 2014; 32: 4179–88
27. Safdar N, Narans L, Gordon B, Maki DG: Comparison of culture screening methods for detection of nasal carriage of methicillin-resistant Staphylococcus aureus: a prospective study comparing 32 methods. J Clin Microbiol, 2003; 41: 3163–66
28. Lee CS, Montalmont B, O’Hara JA et al: Screening for methicillin-resistant Staphylococcus aureus colonization using sponges. Infect Control Hosp Epidemiol, 2015; 36: 28–3